Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nico Gabriel

Showing results (21-30 of 50) with videos related to

Pageof 5
Sort By:
Journal of Managed Care & Specialty Pharmacy|September 12, 2025
Selected drugs, therapeutic alternatives, and price benchmarks for IPAY 2027 Medicare drug price negotiationSean D Sullivan, Emma M Cousin, Kevin H Li, et al.
JAMA|December 5, 2023
Reimbursement to Pharmacies for Generic Drugs by Medicare Part D SponsorsInmaculada Hernandez, Nico Gabriel, Anna Kaltenboeck, et al.
JAMA|March 24, 2025
Projected Out-of-Pocket Savings of the Medicare Part D $2 Drug List ModelInmaculada Hernandez, Nico Gabriel, Yuvraj Pathak, et al.
JAMA|December 2, 2024
Drug Prices Negotiated by Medicare vs US Net Prices and Prices in Other CountriesOlivier J Wouters, Sean D Sullivan, Emma M Cousin, et al.
Neurology. Clinical Practice|February 19, 2026
Changes in List and Net Prices for Multiple Sclerosis Disease-Modifying Therapy, 2013 to 2021Daniel M Hartung, Nico Gabriel, Walid F Gellad, et al.
JAMA Network Open|August 4, 2023
Association Between Redlining and Spatial Access to PharmaciesGiovanni Appolon, Shangbin Tang, Nico Gabriel, et al.
Journal of Managed Care & Specialty Pharmacy|June 21, 2024
Price benchmarks of drugs selected for Medicare price negotiation and their therapeutic alternativesInmaculada Hernandez, Emma M Cousin, Olivier J Wouters, et al.
Journal of Managed Care & Specialty Pharmacy|December 13, 2023
Medicare drug price negotiation: The complexities of selecting therapeutic alternatives for estimating comparative effectivenessInmaculada Hernandez, Emma M Cousin, Olivier J Wouters, et al.
Journal of Managed Care & Specialty Pharmacy|April 27, 2026
Assessment of IPAY 2027 Medicare drug price negotiation maximum fair prices with prices in most-favored nation reference countriesNico Gabriel, Kristi Martin, Emma M Cousin, et al.
Journal of the American Heart Association|December 16, 2021
COVID-19 and Anticoagulation for Atrial Fibrillation: An Analysis of US Nationwide Pharmacy Claims DataInmaculada Hernandez, Nico Gabriel, Meiqi He, et al.
Pageof 5

Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
Journal of Managed Care & Specialty Pharmacy|September 12, 2025
Selected drugs, therapeutic alternatives, and price benchmarks for IPAY 2027 Medicare drug price negotiationSean D Sullivan, Emma M Cousin, Kevin H Li, et al.
JAMA|December 5, 2023
Reimbursement to Pharmacies for Generic Drugs by Medicare Part D SponsorsInmaculada Hernandez, Nico Gabriel, Anna Kaltenboeck, et al.
JAMA|March 24, 2025
Projected Out-of-Pocket Savings of the Medicare Part D $2 Drug List ModelInmaculada Hernandez, Nico Gabriel, Yuvraj Pathak, et al.
JAMA|December 2, 2024
Drug Prices Negotiated by Medicare vs US Net Prices and Prices in Other CountriesOlivier J Wouters, Sean D Sullivan, Emma M Cousin, et al.
Neurology. Clinical Practice|February 19, 2026
Changes in List and Net Prices for Multiple Sclerosis Disease-Modifying Therapy, 2013 to 2021Daniel M Hartung, Nico Gabriel, Walid F Gellad, et al.
JAMA Network Open|August 4, 2023
Association Between Redlining and Spatial Access to PharmaciesGiovanni Appolon, Shangbin Tang, Nico Gabriel, et al.
Journal of Managed Care & Specialty Pharmacy|June 21, 2024
Price benchmarks of drugs selected for Medicare price negotiation and their therapeutic alternativesInmaculada Hernandez, Emma M Cousin, Olivier J Wouters, et al.
Journal of Managed Care & Specialty Pharmacy|December 13, 2023
Medicare drug price negotiation: The complexities of selecting therapeutic alternatives for estimating comparative effectivenessInmaculada Hernandez, Emma M Cousin, Olivier J Wouters, et al.
Journal of Managed Care & Specialty Pharmacy|April 27, 2026
Assessment of IPAY 2027 Medicare drug price negotiation maximum fair prices with prices in most-favored nation reference countriesNico Gabriel, Kristi Martin, Emma M Cousin, et al.
Journal of the American Heart Association|December 16, 2021
COVID-19 and Anticoagulation for Atrial Fibrillation: An Analysis of US Nationwide Pharmacy Claims DataInmaculada Hernandez, Nico Gabriel, Meiqi He, et al.
Pageof 5